Paper31379844
Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.
Deng Z and 18 others. Front Immunol, 2019. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han. Papers, record 31379844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31379844
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Leukemia | Major topic |
| Adult | |
| Asian People | |
| Child | |
| Female | |
| Genotype | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Male | |
| Receptors, KIR |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HHSN261200800001C | CCR NIH HHS | United States | PubMed | PubMed | |
| HHSN261200800001E | NCI NIH HHS | United States | PubMed | PubMed | |
| U01 AI090905 | NIAID NIH HHS | United States | U01AI090905 | PubMed and NIH | NIH RePORTER |
| U19 NS095774 | NINDS NIH HHS | United States | U19NS095774 | PubMed and NIH | NIH RePORTER |
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12493005 | The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12493005 | PubMed |
| 2 | 15470487 | Identification of natural killer cell receptor phenotypes associated with leukemia. | Leukemia | 2004 | https://conductscience.org/library/papers/15470487 | PubMed |
| 3 | 1547670 | Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. | Cytometry | 1992 | https://conductscience.org/library/papers/1547670 | PubMed |
| 4 | 15604012 | CD107a as a functional marker for the identification of natural killer cell activity. | J Immunol Methods | 2004 | https://conductscience.org/library/papers/15604012 | PubMed |
| 5 | 15744340 | CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. | Leukemia | 2005 | https://conductscience.org/library/papers/15744340 | PubMed |
| 6 | 15755898 | Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. | Blood | 2005 | https://conductscience.org/library/papers/15755898 | PubMed |
| 7 | 15896204 | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | Tissue Antigens | 2005 | https://conductscience.org/library/papers/15896204 | PubMed |
| 8 | 16533882 | Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. | J Exp Med | 2006 | https://conductscience.org/library/papers/16533882 | PubMed |
| 9 | 16761016 | Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. | Leukemia | 2006 | https://conductscience.org/library/papers/16761016 | PubMed |
| 10 | 16824023 | The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. | Annu Rev Genomics Hum Genet | 2006 | https://conductscience.org/library/papers/16824023 | PubMed |
| 11 | 17285553 | [Polymorphism of killer cell immunoglobulin-like receptor 2DL3 gene in Zhejiang Han population]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2007 | https://conductscience.org/library/papers/17285553 | PubMed |
| 12 | 17694054 | Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. | Nat Genet | 2007 | https://conductscience.org/library/papers/17694054 | PubMed |
| 13 | 17900288 | HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. | Tissue Antigens | 2007 | https://conductscience.org/library/papers/17900288 | PubMed |
| 14 | 17947671 | Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. | J Immunol | 2007 | https://conductscience.org/library/papers/17947671 | PubMed |
| 15 | 18638659 | Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. | Hum Immunol | 2008 | https://conductscience.org/library/papers/18638659 | PubMed |
| 16 | 18941190 | Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. | J Immunol | 2008 | https://conductscience.org/library/papers/18941190 | PubMed |
| 17 | 19342631 | NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. | J Immunol | 2009 | https://conductscience.org/library/papers/19342631 | PubMed |
| 18 | 19383914 | Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. | Cancer Res | 2009 | https://conductscience.org/library/papers/19383914 | PubMed |
| 19 | 19450876 | Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. | Leuk Res | 2010 | https://conductscience.org/library/papers/19450876 | PubMed |
| 20 | 19493232 | Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. | Tissue Antigens | 2009 | https://conductscience.org/library/papers/19493232 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42712389 | Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42712389 | PubMed |
| 41717357 | KIR AA individuals possess strong inhibitory KIR alleles alongside HLA ligands that are protective against leukemia in the Chinese population. | Front Genet | 2025 | https://conductscience.org/library/papers/41717357 | PubMed |
| 36699439 | Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort. | Indian J Hematol Blood Transfus | 2023 | https://conductscience.org/library/papers/36699439 | PubMed |
| 36689727 | Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. | Blood Adv | 2023 | https://conductscience.org/library/papers/36689727 | PubMed |
| 35561968 | Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health. | J Allergy Clin Immunol Pract | 2022 | https://conductscience.org/library/papers/35561968 | PubMed |
| 35192601 | Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/35192601 | PubMed |
| 33995358 | High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han. | Front Immunol | 2021 | https://conductscience.org/library/papers/33995358 | PubMed |
| 33986753 | Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia. | Front Immunol | 2021 | https://conductscience.org/library/papers/33986753 | PubMed |
| 33616658 | Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians. | Mol Biol Evol | 2021 | https://conductscience.org/library/papers/33616658 | PubMed |
| 33257819 | Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients. | Genes Immun | 2020 | https://conductscience.org/library/papers/33257819 | PubMed |
| 32420357 | KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32420357 | PubMed |
| 32269692 | Killer cell immunoglobulin-like receptor gene cluster predisposes to susceptibility to B-cell acute lymphoblastic leukemia in Chinese children. | Int J Clin Exp Pathol | 2020 | https://conductscience.org/library/papers/32269692 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31379844
GET https://conductscience.org/api/papers/v1/31379844/references?page=2